Search alternatives:
significant barrier » significant burden (Expand Search)
barrier decrease » larger decrease (Expand Search), barrier disease (Expand Search), marked decrease (Expand Search)
small decrease » small increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant barrier » significant burden (Expand Search)
barrier decrease » larger decrease (Expand Search), barrier disease (Expand Search), marked decrease (Expand Search)
small decrease » small increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
21
Inhibition of PGAM5 and apoptosis alleviated the rTsSPc-damaged Caco-2 monolayer barrier integrity.
Published 2025Subjects: -
22
-
23
-
24
-
25
S1 File -
Published 2024“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”
-
26
Experimental treatments and groups.
Published 2024“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”
-
27
Primers for RT-qPCR.
Published 2024“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”
-
28
Effects of busulfan treatment on the ultrastructure of the blood-testis barrier (BTB).
Published 2025Subjects: -
29
-
30
-
31
-
32
PGAM5 knockdown prevented rTsSPc from disrupting Caco-2 monolayer integrity.
Published 2025Subjects: -
33
-
34
-
35
-
36
-
37
-
38
Local consumer escalation process (adapted from Local Health Network (CALHN) procedure 2019) [16].
Published 2025Subjects: -
39
-
40